Immurx

Provider of toll-like receptor (TLR) and CD40 agonists for the treatment of cancer and infectious disease

placeLebanon, New Hampshire, United States calendar_todayFounded 2006 language immurx.com

Registered entities

Innovation

2 patent families (2 granted) — focus: Human necessities; filing pace dormant. Cited 111 times.

YearFilings
20132
20141
20161
20191

Investor mix

3 investors on record.

Investor typeCountShare
Other / undisclosed3100%
Coming soon